Amélioration notable de la visibilité sur les perspectives règlementaires et commerciales aux États-Unis depuis les derniers échanges avec la FDA.
- Essential Pharma strengthens Board with the appointment of Jonathan Arnold as Non-Executive Director - April 30, 2025
- CGTN: Why the Chu Silk Manuscripts should be returned to China - April 30, 2025
- On Natural Gas Transmission System Operator’s Revenue Cap ofRegulated Activities for 2026 - April 30, 2025